ConductScience.org, home

Paper41003134

Metabolic Signature of FLT3-Mutated AML: Clinical and Therapeutic Implications.

Banella C and 5 others. J Pers Med, 2025. Cited by 2 papers, by iCite.

Cite this record

ConductScience Library. Metabolic Signature of FLT3-Mutated AML: Clinical and Therapeutic Implications. Papers, record 41003134. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41003134

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Metabolic Signature of FLT3-Mutated AML: Clinical and Therapeutic Implications.
PubMed
Journal
J Pers Med
PubMed
Year
2025
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
2
iCite
Revised in PubMed
2025-09-28
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Banella CCristina
2Catalano GGianfranco
3Calvani MMaurahttps://orcid.org/0000-0003-0750-4706
4Candi EEleonora
5Noguera NINelida Ineshttps://orcid.org/0000-0001-7682-862X
6Travaglini SSerenahttps://orcid.org/0000-0002-5411-1502

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
DR3392Italian Association for Cancer ResearchPubMed
M4C2I1.3Ministero dell'università e della ricercaPubMed

Source PubMed

Download CSV of grants

References190

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
132786187Azacitidine and Venetoclax in Previously Untreated Acute Myeloid Leukemia.N Engl J Med2020https://conductscience.org/library/papers/32786187PubMed
223333149BCL-2 inhibition targets oxidative phosphorylation and selectively eradicates quiescent human leukemia stem cells.Cell Stem Cell2013https://conductscience.org/library/papers/23333149PubMed
328283480Leveraging increased cytoplasmic nucleoside kinase activity to target mtDNA and oxidative phosphorylation in AML.Blood2017https://conductscience.org/library/papers/28283480PubMed
526219591An MTCH2 pathway repressing mitochondria metabolism regulates haematopoietic stem cell fate.Nat Commun2015https://conductscience.org/library/papers/26219591PubMed
625547679Tyrosine kinase inhibition in leukemia induces an altered metabolic state sensitive to mitochondrial perturbations.Clin Cancer Res2015https://conductscience.org/library/papers/25547679PubMed
736831684Repurposing Atovaquone as a Therapeutic against Acute Myeloid Leukemia (AML): Combination with Conventional Chemotherapy Is Feasible and Well Tolerated.Cancers (Basel)2023https://conductscience.org/library/papers/36831684PubMed
827540013Targeting FLT3-ITD signaling mediates ceramide-dependent mitophagy and attenuates drug resistance in AML.Blood2016https://conductscience.org/library/papers/27540013PubMed
929326164The glutamine transporter ASCT2 (SLC1A5) promotes tumor growth independently of the amino acid transporter LAT1 (SLC7A5).J Biol Chem2018https://conductscience.org/library/papers/29326164PubMed
1039902131Mitochondrial abnormalities as a target of intervention in acute myeloid leukemia.Front Oncol2024https://conductscience.org/library/papers/39902131PubMed
1135797463Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN.Blood2022https://conductscience.org/library/papers/35797463PubMed
1235962843Invariant NKT cells metabolically adapt to the acute myeloid leukaemia environment.Cancer Immunol Immunother2023https://conductscience.org/library/papers/35962843PubMed
1338179723The Potential Transcriptomic and Metabolomic Mechanisms of ATO and ATRA in Treatment of FLT3-ITD Acute Myeloid Leukemia.Technol Cancer Res Treat2024https://conductscience.org/library/papers/38179723PubMed
1437349598MCL1 regulates AML cells metabolism via direct interaction with HK2. Metabolic signature at onset predicts overall survival in AMLs' patients.Leukemia2023https://conductscience.org/library/papers/37349598PubMed
1531819187New aspects of amino acid metabolism in cancer.Br J Cancer2020https://conductscience.org/library/papers/31819187PubMed
1629472349Clinical relevance of IDH1/2 mutant allele burden during follow-up in acute myeloid leukemia. A study by the French ALFA group.Haematologica2018https://conductscience.org/library/papers/29472349PubMed
1718287083Nrf2 mediates cancer protection but not prolongevity induced by caloric restriction.Proc Natl Acad Sci U S A2008https://conductscience.org/library/papers/18287083PubMed
1816998484Targeting of CD44 eradicates human acute myeloid leukemic stem cells.Nat Med2006https://conductscience.org/library/papers/16998484PubMed
1925215489Cell-state-specific metabolic dependency in hematopoiesis and leukemogenesis.Cell2014https://conductscience.org/library/papers/25215489PubMed
2030975911FLT3-ITD cooperates with Rac1 to modulate the sensitivity of leukemic cells to chemotherapeutic agents via regulation of DNA repair pathways.Haematologica2019https://conductscience.org/library/papers/30975911PubMed
2124014241Inhibiting glutamine uptake represents an attractive new strategy for treating acute myeloid leukemia.Blood2013https://conductscience.org/library/papers/24014241PubMed

See all 190 referencesDownload CSV of references

Cited by2

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.

PMIDTitleJournalYearIn PapersSource
42797430Exploiting Metabolic Vulnerabilities in Acute Myeloid Leukemia: Rationale and Evidence for Combining Metabolic Modulators with Conventional Chemotherapy.Pharmaceuticals (Basel)2026https://conductscience.org/library/papers/42797430PubMed
41463291Mitochondrial Dysfunction in Apoptosis-Resistant Acute Myeloid Leukemia Cells During a Sterile Inflammatory Response.Biomolecules2025https://conductscience.org/library/papers/41463291PubMed

Download CSV of cited by

Genes76

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
AKT1207PubTator's text mininghttps://conductscience.org/library/genes/207NCBI Gene
ASXL1171023PubTator's text mininghttps://conductscience.org/library/genes/171023NCBI Gene
ATF622926PubTator's text mininghttps://conductscience.org/library/genes/22926NCBI Gene
BCL2596PubTator's text mininghttps://conductscience.org/library/genes/596NCBI Gene
CD34947PubTator's text mininghttps://conductscience.org/library/genes/947NCBI Gene
CD38952PubTator's text mininghttps://conductscience.org/library/genes/952NCBI Gene
CEBPA1050PubTator's text mininghttps://conductscience.org/library/genes/1050NCBI Gene
CERS110715PubTator's text mininghttps://conductscience.org/library/genes/10715NCBI Gene
CERT110087PubTator's text mininghttps://conductscience.org/library/genes/10087NCBI Gene
CHEK11111PubTator's text mininghttps://conductscience.org/library/genes/1111NCBI Gene
CPT1A1374PubTator's text mininghttps://conductscience.org/library/genes/1374NCBI Gene
CYBA1535PubTator's text mininghttps://conductscience.org/library/genes/1535NCBI Gene
DDIT31649PubTator's text mininghttps://conductscience.org/library/genes/1649NCBI Gene
DNMT3A1788PubTator's text mininghttps://conductscience.org/library/genes/1788NCBI Gene
EPHB22048PubTator's text mininghttps://conductscience.org/library/genes/2048NCBI Gene
ERN12081PubTator's text mininghttps://conductscience.org/library/genes/2081NCBI Gene
FLT32322PubTator's text mininghttps://conductscience.org/library/genes/2322NCBI Gene
G6PD2539PubTator's text mininghttps://conductscience.org/library/genes/2539NCBI Gene
GAPDH2597PubTator's text mininghttps://conductscience.org/library/genes/2597NCBI Gene
GLS2744PubTator's text mininghttps://conductscience.org/library/genes/2744NCBI Gene

See all 76 genesDownload CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41003134

GET https://conductscience.org/api/papers/v1/41003134/references?page=2